5 resultados
Purpose: Monitoring neurological side-effects in experimental therapy for diffuse intrinsic pontine glioma (DIPG) can be challenging. We aimed to develop a neurological scale that could be used by non-specialists to quantify neurological
Diffuse intrinsic pontine glioma (DIPG) is a devastating cancer of childhood and adolescence.METHODS
The study included patients between 3 and 20 years with clinically and radiologically confirmed
DIPG. Primary endpoint was 6-month progression-free
Introduction: This study presented pediatric DIPG 's biopsy with frameless Neuronavigation.
Patients and methods: We report our experience about 10 patients who had Diffuse
We present a case of inadvertent high-dose therapy with temozolomide in a child with recurrent diffuse intrinsic pontine glioma followed by a rapid clinical response. The patient was a 7-year-old boy who initially presented with a history of left facial palsy, double vision, headache, and ataxia.
OBJECTIVE
Histone H3.3 (H3F3A) mutation in the codon for lysine 27 (K27M) has been found as driver mutations in pediatric glioblastoma and has been suggested to play critical roles in the pathogenesis of thalamic gliomas and diffuse intrinsic pontine gliomas. We report a case of thalamic glioma with